Healthcare -
Biotechnology - NASDAQ - US
$ 2.01
8.65 %
$ 166 M
Market Cap
-1.3
P/E
STRO - COST OF REVENUE
Cost of Revenue STRO - Sutro Biopharma, Inc.
6.82 M
LAST VALUE
-16.49%
2 YEAR CAGR
-33.96%
5 YEAR CAGR
0.00%
10 YEAR CAGR